[Neuromuscular disorders due to adverse effects of antiparkinson agents].
Hattori
Nobutaka
N
D000547:Amantadine / Q000009:adverse effects; D000978:Antiparkinson Agents / Q000009:adverse effects*; D002396:Catechols / Q000009:adverse effects; D018491:Dopamine Agonists / Q000009:adverse effects; D006801:Humans; D007980:Levodopa / Q000009:adverse effects; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D009468:Neuromuscular Diseases / Q000139:chemically induced*; D009570:Nitriles / Q000009:adverse effects; D014282:Trihexyphenidyl / Q000009:adverse effects